The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

The updated tally extends the scope beyond what was previously described by company Chief Executive Andrew Witty.

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

The City of Greensboro, North Carolina, which provides public safety, emergency, and health services to over 300,000 residents and spends millions annually on insulin medications, filed a lawsuit last ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...